The epidemiology of neuromuscular disorders: A comprehensive overview of the literature

Journal of Neuromuscular Diseases

Volumn 2, Issue 1, 2015, Pages 73-85

  Deenen, Johanna C W ^a   Horlings, Corinne G C ^b   Verschuuren, Jan J G M ^b   Verbeek, André L M ^a   Van Engelen, Baziel G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Epidemiology; Incidence; Neuromuscular diseases; Prevalence

Indexed keywords

ADULT; AGE DISTRIBUTION; BECKER MUSCULAR DYSTROPHY; DISEASE SURVEILLANCE; EATON LAMBERT SYNDROME; EMERY DREIFUSS MUSCULAR DYSTROPHY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEMALE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR NEUROPATHY; MUSCULAR DYSTROPHY; MYOTONIC DYSTROPHY; NEUROMUSCULAR DISEASE; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PHENOTYPE; POPULATION RESEARCH; POSTPOLIOMYELITIS SYNDROME; PREVALENCE; PRIORITY JOURNAL; REVIEW;

EID: 84946471697     PISSN: 22143599     EISSN: 22143602     Source Type: Journal    
DOI: 10.3233/JND-140045     Document Type: Review

References (179)

1. van Deutekom, J. C., Bremmer-Bout, M., Janson, A. A., Ginjaar, I. B., Baas, F., den Dunnen, J. T., van Ommen, G. J. Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum Mol Genet. 2001; 10(15): 1547-1554.
2. Lemmers, R. J., van der Vliet, P. J., Klooster, R., Sacconi, S., Camano, P., Dauwerse, J. G., Snider, L., Straasheijm, K. R., van Ommen, G. J., Padberg, G.W., Miller, D. G., Tapscott, S. J., Tawil, R., Frants, R. R., van der Maarel, S. M. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science (80-). 2010; 329(5999): 1650-1653.
3. Emery, A. E. Population frequencies of inherited neuromuscular diseases-a world survey. Neuromuscul Disord. 1991; 1(1): 19-29.
4. Emery, A. E. Population frequencies of neuromuscular diseases-II. Amyotrophic lateral sclerosis (motor neurone disease). Neuromuscul Disord. 1991; 1(5): 323-325.
5. Pohlschmidt, M., Meadowcroft, R. Muscle disease: The impact - Incidence and Prevalence of Neuromuscular Conditions in the UK. London: Muscular Dystrophy Campaign, 2010:15.
6. Prevalence of rare diseases: Bibliographic data. Orphanet Report Series 2013 June 2013 [cited 2014 May 22]; number 1:[Available from: http://www.orpha.net/ orphacom/cahiers/docs/GB/Prevalence of rare diseases by alphabetical list.pdf.
7. Emery AEH. Diagnostic criteria for neuromuscular disorders. Place. Published: Royal Society of Medicine Press; 1997.
8. MacMillan, J. C., Harper, P. S. Single-gene neurological disorders in South Wales: An epidemiological study. Ann Neurol. 1991; 30(3): 411-414.
9. Ahlstrom, G., Gunnarsson, L. G., Leissner, P., Sjoden, P. O. Epidemiology of neuromuscular diseases, including the postpolio sequelae, in a Swedish county. Neuroepidemiology. 1993; 12(5): 262-269.
10. Hughes, M. I., Hicks, E. M., Nevin, N. C., Patterson, V. H. The prevalence of inherited neuromuscular disease in Northern Ireland. Neuromuscul Disord. 1996; 6(1): 69-73.
11. Ludvigsson, P., Olafsson, E., Hauser, W. A. Spinal muscular atrophy. Incidence in Iceland. Neuroepidemiology. 1999; 18(5): 265-269.
12. Zaldivar, T., Montejo, Y., Acevedo, A. M., Guerra, R., Vargas, J., Garofalo, N., Alvarez, R., Alvarez, M. A., Hardiman, O. Evidence of reduced frequency of spinal muscular atrophy type I in the Cuban population. Neurology. 2005(4); 65:636-638.
13. Norwood, F. L., Harling, C., Chinnery, P. F., Eagle, M., Bushby, K., Straub, V. Prevalence of genetic muscle disease in Northern England: In-depth analysis of a muscle clinic population. Brain. 2009; 132(Pt 11): 3175-3186.
14. Annegers, J.F., Appel, S., Lee, J. R., Perkins, P. Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988. Arch Neurol. 1991; 48(6): 589-593.
15. Tysnes, O. B., Vollset, S. E., Aarli, J. A. Epidemiology of amyotrophic lateral sclerosis in Hordaland county, western Norway. Acta Neurol Scand. 1991; 83(5): 280-285.
16. Giagheddu, M., Mascia, V., Cannas, A., Pirastru, M. I., Sanna, F., Rachele, M. G., Brundu, A., Murgia, B. Amyotrophic lateral sclerosis in Sardinia, Italy: An epidemiologic study. Acta Neurol Scand. 1993; 87(6): 446-454.
17. Bettoni, L., Bazzani, M., Bortone, E., Dascola, I., Pisani, E., Mancia, D. Steadiness of amyotrophic lateral sclerosis in the province of Parma, Italy, 1960-1990. Acta Neurol Scand. 1994; 90(4): 276-280.
18. Alcaz, S., Jarebinski, M., Pekmezovic, T., Stevic- Marinkovic, Z., Pavlovic, S., Apostolski, S. Epidemiological and clinical characteristics of ALS in Belgrade, Yugoslavia. Acta Neurol Scand. 1996; 94(4): 264-268.
19. Guidetti, D., Bondavalli, M., Sabadini, R., Marcello, N., Vinceti, M., Cavalletti, S., Marbini, A., Gemignani, F., Colombo, A., Ferrari, A., Vivoli, G., Solime, F. Epidemiological survey of amyotrophic lateral sclerosis in the province of Reggio Emilia, Italy: Influence of environmental exposure to lead. Neuroepidemiology. 1996; 15(6): 301-312.
20. Gross-Paju, K., Oopik, M., Luus, S. M., Kalbe, I., Puksa, L., Lepik, T., Kaasik, A. E. Motor neurone disease in South Estonia. Diagnosis and incidence rate. Acta Neurol Scand. 1998; 98(1): 22-28.
21. Yoshida, S., Uebayashi, Y., Kihira, T., Kohmoto, J., Wakayama, I., Taguchi, S., Yase, Y. Epidemiology of motor neuron disease in the Kii Peninsula of Japan, 1989-1993: Active or disappearing focus? J Neurol Sci. 1998; 155(2): 146-155.
22. Preux, P. M., Druet-Cabanac, M., Couratier, P., Debrock, C., Truong, T., Marcharia, W., Vallat, J. M., Dumas, M., Boutros-Toni, F. Estimation of the amyotrophic lateral sclerosis incidence by capture-recapture method in the Limousin region of France. J Clin Epidemiol. 2000; 53(10): 1025-1029.
23. Sorenson, E. J., Stalker, A. P., Kurland, L. T., Windebank, A. J. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology. 2002; 59(2): 280-282.
24. Govoni, V., Granieri, E., Capone, J., Manconi, M., Casetta, I. Incidence of amyotrophic lateral sclerosis in the local health district of Ferrara, Italy, 1964-1998. Neuroepidemiology. 2003; 22(4): 229-234.
25. Mandrioli, J., Faglioni, P., Merelli, E., Sola, P. The epidemiology of ALS in Modena, Italy. Neurology. 2003; 60(4): 683-689.
26. Kihira, T., Yoshida, S., Hironishi, M., Miwa, H., Okamato, K., Kondo, T. Changes in the incidence of amyotrophic lateral sclerosis inWakayama, Japan. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005; 6(3): 155-163.
27. Logroscino, G., Beghi, E., Zoccolella, S., Palagano, R., Fraddosio, A., Simone, I. L., Lamberti, P., Lepore, V., Serlenga, L. Incidence of amyotrophic lateral sclerosis in southern Italy: A population based study. J Neurol Neurosurg Psychiatry. 2005; 76(8): 1094-1098.
28. Abhinav, K., Stanton, B., Johnston, C., Hardstaff, J., Orrell, R. W., Howard, R., Clarke, J., Sakel, M., Ampong, M. A., Shaw, C. E., Leigh, P. N., Al-Chalabi, A. Amyotrophic lateral sclerosis in South-East England: A population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). Neuroepidemiology. 2007; 29(1-2): 44-48.
29. Beghi, E., Millul, A., Micheli, A., Vitelli, E., Logroscino, G. Incidence of ALS in Lombardy, Italy. Neurology. 2007; 68(2): 141-145.
30. Bonaparte, J. P., Grant, I. A., Benstead, T. J., Murray, T. J., Smith, M. ALS incidence in Nova Scotia over a 20-yearperiod: A prospective study. Can J Neurol Sci. 2007; 34(1): 69-73.
31. Forbes, R. B., Colville, S., Parratt, J., Swingler, R. J. The incidence of motor nueron disease in Scotland. J Neurol. 2007; 254(7): 866-869.
32. Bonvicini, F., Vinceti, M., Marcello, N., Rodolfi, R., Rinaldi, M. The epidemiology of amyotrophic lateral sclerosis in Reggio Emilia, Italy. Amyotroph Lateral Scler. 2008; 9(6): 350-353.
33. O'Toole, O., Traynor, B. J., Brennan, P., Sheehan, C., Frost, E., Corr, B., Hardiman, O. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008; 79(1): 30-32.
34. Murphy, M., Quinn, S., Young, J., Parkin, P., Taylor, B. Increasing incidence of ALS in Canterbury, New Zealand: A 22-year study. Neurology. 2008; 71(23): 1889-1895.
35. Turabelidze, G., Zhu, B. P., Schootman, M., Malone, J. L., Horowitz, S., Weidinger, J., Williamson, D., Simoes, E. An epidemiologic investigation of amyotrophic lateral sclerosis in Jefferson County, Missouri, 1998-2002. Neurotoxicology. 2008; 29(1): 81-86.
36. Vazquez, M.C., Ketzoian, C., Legnani, C., Rega, I., Sanchez, N., Perna, A., Penela, M., Aguirrezabal, X., Druet-Cabanac, M., Medici, M. Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay:Apopulation-based study. Neuroepidemiology. 2008; 30(2): 105-111.
37. Chio, A., Mora, G., Calvo, A., Mazzini, L., Bottacchi, E., Mutani, R. Epidemiology of ALS in Italy: A 10- year prospective population-based study. Neurology. 2009; 72(8): 725-731.
38. Cima, V., Logroscino, G., D'Ascenzo, C., Palmieri, A., Volpe, M., Briani, C., Pegoraro, E., Angelini, C., Soraru, G. Epidemiology of ALS in Padova district, Italy, from 1992 to 2005. Eur J Neurol. 2009; 16(8): 920-924.
39. Fang, F., Valdimarsdottir, U., Bellocco, R., Ronnevi, L. O., Sparen, P., Fall, K., Ye, W. Amyotrophic lateral sclerosis in Sweden, 1991-2005. Arch Neurol. 2009; 66(4): 515-519.
40. Marin, B., Gil, J., Preux, P. M., Funalot, B., Couratier, P. Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997-2007. Amyotroph Lateral Scler. 2009; 10(4): 216-220.
41. Logroscino, G., Traynor, B. J., Hardiman, O., Chio, A., Mitchell, D., Swingler, R. J., Millul, A., Benn, E., Beghi, E. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010; 81(4): 385-390.
42. Sajjadi, M., Etemadifar, M., Nemati, A., Ghazavi, H., Basiri, K., Khoundabi, B., Mousavi, S. A., Kabiri, P., Maghzi, A. H. Epidemiology of amyotrophic lateral sclerosis in Isfahan, Iran. Eur J Neurol. 2010; 17(7): 984-989.
43. Georgoulopoulou, E., Vinceti, M., Bonvicini, F., Sola, P., Goldoni, C. A., De Girolamo, G., Ferraro, D., Nichelli, P., Mandrioli, J. Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study. Amyotroph Lateral Scler. 2011; 12(6): 451-457.
44. Gundersen, M. D., Yaseen, R., Midgard, R. Incidence and clinical features of amyotrophic lateral sclerosis in More and Romsdal County, Norway. Neuroepidemiology. 2011; 37(1): 58-63.
45. Huisman, M. H., de Jong, S. W., van Doormaal, P. T., Weinreich, S. S., Schelhaas, H. J., van der Kooi, A. J., de Visser, M., Veldink, J. H., van den Berg, L. H. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry. 2011; 82(10): 1165-1170.
46. Govoni, V., Cesnik, E., Casetta, I., Tugnoli, V., Tola, M. R., Granieri, E. Temporal trend of amyotrophic lateral sclerosis incidence in southern Europe: A population study in the health district of Ferrara, Italy. J Neurol. 2012; 259(8): 1623-1631.
47. Joensen, P. Incidence of amyotrophic lateral sclerosis in the Faroe Islands. Acta Neurol Scand. 2012; 126(1): 62-66.
48. Ragonese, P., Cellura, E., Aridon, P., D'Amelio, M., Spataro, R., Taiello, A. C., Maimone, D., La Bella, V., Savettieri, G. Incidence of amyotrophic lateral sclerosis in Sicily: A population based study. Amyotroph Lateral Scler. 2012; 13(3): 284-287.
49. Wagner, L., Archer, N. P., Williamson, D. M., Henry, J. P., Schiffer, R., Jackson, C. E. Prevalence of amyotrophic lateral sclerosis in Texas, 1998-2003. Tex Med. 2012; 108(5): e1.
50. Bandettini di Poggio, M., Sormani. M. P., Truffelli, R., Mandich, P., Origone, P., Verdiani, S., Mantero, V., Scialo, C., Schenone, A., Mancardi, G. L., Caponnetto, C., Ligals. Clinical epidemiology of ALS in Liguria, Italy. Amyotrophic lateral sclerosis & frontotemporal degeneration. 2013; 14(1): 52-57.
51. Bettini, M., Vicens, J., Giunta, D. H., Rugiero, M., Cristiano, E. Incidence and prevalence of amyotrophic lateral sclerosis in an HMO of Buenos Aires, Argentina. Amyotrophic lateral sclerosis&frontotemporal degeneration. 2013; 14(7-8): 598-603.
52. Drigo, D., Verriello, L., Clagnan, E., Eleopra, R., Pizzolato, G., Bratina, A., D'Amico, D., Sartori, A., Mase, G., Simonetto, M., Lazzarino de Lorenzo, L., Cecotti, L., Zanier, L., Pisa, F., Barbone, F. The incidence of amyotrophic lateral sclerosis in FriuliVenezia Giulia, Italy, from 2002 to 2009:A retrospective population-based study. Neuroepidemiology. 2013; 41(1): 54-61.
53. Giagheddu, M., Puggioni, G., Tacconi, P., Pirastru, M. I., Cannas, A., Tamburini, G., Congia, S. Amyotrophic lateral sclerosis in Sardinia (Italy): Epidemiologic features from 1957 to 2000. Acta Neurol Scand. 2013; 127(4): 251-259.
54. Lareau-Trudel, E., Fortin, E., Gauthier, M., Lavoie, S., Morissette, E., Mathieu, J. Epidemiological surveillance of amyotrophic lateral sclerosis in Saguenay region. Can J Neurol Sci. 2013; 40(5): 705-709.
55. Linden-Junior, E., Becker, J., Schestatsky, P., Rotta, F. T., Marrone, C. D., Gomes, I. Prevalence of amyotrophic lateral sclerosis in the city of Porto Alegre, in Southern Brazil. Arquivos de neuro-psiquiatria. 2013; 71(12): 959-962.
56. Migliaretti, G., Berchialla, P., Dalmasso, P., Cavallo, F., Chio, A. Amyotrophic lateral sclerosis in Piedmont (Italy): A Bayesian spatial analysis of the incident cases. Amyotrophic lateral sclerosis & frontotemporal degeneration. 2013; 14(1): 58-65.
57. Pugliatti, M., Parish, L. D., Cossu, P., Leoni, S., Ticca, A., Saddi, M. V., Ortu, E., Traccis, S., Borghero, G., Puddu, R., Chio, A., Pirina, P. Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995-2009. J Neurol. 2013; 260(2): 572-579.
58. Wittie, M., Nelson, L. M., Usher, S., Ward, K., Benatar, M. Utility of capture-recapture methodology to assess completeness of amyotrophic lateral sclerosis case ascertainment. Neuroepidemiology. 2013; 40(2): 133-141.
59. Doi, Y., Atsuta, N., Sobue, G., Morita, M., Nakano, I. Prevalence and Incidence of Amyotrophic Lateral Sclerosis in Japan. J Epidemiol. 2014; 24(6): 494-499.
60. Mandrioli, J., Biguzzi, S., Guidi, C., Venturini, E., Sette, E., Terlizzi, E., Ravasio, A., Casmiro, M., Salvi, F., Liguori, R., Rizzi, R., Pietrini, V., Chierici, E., Santangelo, M., Granieri, E., Mussuto, V., Borghi, A., Rinaldi, R., Fini, N., Georgoulopoulou, E., De Pasqua, S., Vinceti, M., Bonvicini, F., Errals, G., Ferro, S., D'Alessandro, R. Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): A population based study. Amyotrophic lateral sclerosis & frontotemporal degeneration. 2014; 15(3-4): 262-268.
61. Mehta, P., Antao, V., Kaye, W., Sanchez, M., Williamson, D., Bryan, L., Muravov, O., Horton, K. Division of T, Human Health Sciences AfTS, Disease Registry AG, Centers for Disease C, Prevention. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011. MMWR Surveill Summ. 2014; 63(Suppl 7): 1-14.
62. Uenal, H., Rosenbohm, A., Kufeldt, J., Weydt, P., Goder, K., Ludolph, A., Rothenbacher, D., Nagel, G., Group ALSrS. Incidence and geographical variation of amyotrophic lateral sclerosis (ALS) in Southern Germany-completeness of the ALS registry Swabia. PLoS One. 2014; 9(4): e93932.
63. Wolf, J., Wohrle, J. C., Palm, F., Nix, W. A., Maschke, M., Safer, A., Becher, H., Grau, A. J. Incidence of amyotrophic lateral sclerosis in Rhineland-Palatinate, Germany. Amyotrophic lateral sclerosis & frontotemporal degeneration. 2014; 15(3-4): 269-274.
64. Takemura, J., Saeki, S., Hachisuka, K., Aritome, K. Prevalence of post-polio syndrome based on a cross-sectional survey in Kitakyushu, Japan. J Rehabil Med. 2004; 36(1): 1-3.
65. Holmberg, B. H. Charcot-Marie-Tooth disease in northern Sweden: An epidemiological and clinical study. Acta Neurol Scand. 1993; 87(5): 416-422.
66. MacMillan, J. C., Harper, P. S. The Charcot-Marie-Tooth syndrome: Clinical aspects from a population study in South Wales, UK. Clin Genet. 1994; 45(3): 128-134.
67. Kurihara, S., Adachi, Y., Wada, K., Awaki, E., Harada, H., Nakashima, K. An epidemiological genetic study of Charcot-Marie-Tooth disease in Western Japan. Neuroepidemiology. 2002; 21(5): 246-250.
68. Guthmundsson, B., Olafsson, E., Jakobsson, F., Luthvigsson, P. Prevalence of symptomatic Charcot-Marie-Tooth disease in Iceland: A study of a well-defined population. Neuroepidemiology. 2010; 34(1): 13-17.
69. Nicolaou, P., Zamba-Papanicolaou, E., Koutsou, P., Kleopa, K. A., Georghiou, A., Hadjigeorgiou, G., Papadimitriou, A., Kyriakides, T., Christodoulou, K. Charcot-Marie-Tooth disease in Cyprus: Epidemiological, clinical and genetic characteristics. Neuroepidemiology. 2010; 35(3): 171-177.
70. Braathen, G. J., Sand, J. C., Lobato, A., Hoyer, H., Russell, M. B. Genetic epidemiology of Charcot-Marie-Tooth in the general population. Eur J Neurol. 2011; 18(1): 39-48.
71. Mladenovic, J., Milic Rasic, V., Keckarevic Markovic, M., Romac, S., Todorovic, S., Rakocevic Stojanovic, V., Kisic Tepavcevic, D., Hofman, A., Pekmezovic, T. Epidemiology of Charcot-Marie-Tooth disease in the population of Belgrade, Serbia. Neuroepidemiology. 2011; 36(3): 177-182.
72. Foley, C., Schofield, I., Eglon, G., Bailey, G., Chinnery, P. F., Horvath, R. Charcot-Marie-Tooth disease in Northern England. J Neurol Neurosurg Psychiatry. 2012; 83(5): 572-573.
73. Kusumi, M., Nakashima, K., Nakayama, H., Takahashi, K. Epidemiology of inflammatory neurological and inflammatory neuromuscular diseases in Tottori Prefecture, Japan. Psychiatry Clin Neurosci. 1995; 49(3): 169-174.
74. Lunn, M. P., Manji, H., Choudhary, P. P., Hughes, R. A., Thomas, P. K. Chronic inflammatory demyelinating polyradiculoneuropathy: A prevalence study in south east England. J Neurol Neurosurg Psychiatry. 1999; 66(5): 677-680.
75. Mygland, A., Monstad, P. Chronic polyneuropathies inVest- Agder, Norway. Eur J Neurol. 2001; 8(2): 157-165.
76. Chio, A., Cocito, D., Bottacchi, E., Buffa, C., Leone, M., Plano, F., Mutani, R., Calvo, A. Idiopathic chronic inflammatory demyelinating polyneuropathy: An epidemiological study in Italy. J Neurol Neurosurg Psychiatry. 2007; 78(12): 1349-1353.
77. Laughlin, R. S., Dyck, P. J., Melton, L. J., 3rd, Leibson, C., Ransom, J. Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurology. 2009; 73(1): 39-45.
78. Rajabally, Y. A., Simpson, B. S., Beri, S., Bankart, J., Gosalakkal, J. A. Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: Study of aUKpopulation. Muscle Nerve. 2009; 39(4): 432-438.
79. Mahdi-Rogers, M., Hughes, R. A. Epidemiology of chronic inflammatory neuropathies in southeast England. Eur J Neurol. 2014; 21(1): 28-33.
80. Leone, M., Brignolio, F., Rosso, M. G., Curtoni, E. S., Moroni, A., Tribolo, A., Schiffer, D. Friedreich's ataxia: A descriptive epidemiological study in an Italian population. Clin Genet. 1990; 38(3): 161-169.
81. Filla, A., De Michele, G., Marconi, R., Bucci, L., Carillo, C., Castellano, A. E., Iorio, L., Kniahynicki, C., Rossi, F., Campanella, G. Prevalence of hereditary ataxias and spastic paraplegias in Molise, a region of Italy. J Neurol. 1992; 239(6): 351-353.
82. Lopez-Arlandis, J. M., Vilchez, J. J., Palau, F., Sevilla, T. Friedreich's ataxia: An epidemiological study in Valencia, Spain, based on consanguinity analysis. Neuroepidemiology. 1995; 14(1): 14-19.
83. Zortea, M., Armani, M., Pastorello, E., Nunez, G. F., Lombardi, S., Tonello, S., Rigoni, M.T., Zuliani, L., Mostacciuolo, M. L., Gellera, C., Di Donato, S., Trevisan, C. P. Prevalence of inherited ataxias in the province of Padua, Italy. Neuroepidemiology. 2004; 23(6): 275-280.
84. Coutinho, P., Ruano, L., Loureiro, J. L., Cruz, V. T., Barros, J., Tuna, A., Barbot, C., Guimaraes, J., Alonso, I., Silveira, I., Sequeiros, J., Marques Neves, J., Serrano, P., Silva, M. C. Hereditary ataxia and spastic paraplegia in Portugal: A population-based prevalence study. JAMAneurology. 2013; 70(6): 746-755.
85. Meretoja, P., Silander, K., Kalimo, H., Aula, P., Meretoja, A., Savontaus, M. L. Epidemiology of hereditary neuropathy with liability to pressure palsies (HNPP) in south western Finland. Neuromuscul Disord. 1997; 7(8): 529-532.
86. Winner, S. J., Evans, J. G. Age-specific incidence of Guillain-Barre syndrome in Oxfordshire. Q J Med. 1990; 77(284): 1297-1304.
87. Paolino, E., Govoni, V., Tola, M. R., Casetta, I., Granieri, E. Incidence of the Guillain-Barre syndrome in Ferrara, northern Italy, 1981-1987. Neuroepidemiology. 1991; 10(3): 105-111.
88. Hoppock, K. C., Greer, G. G., Walling, A. D. The incidence of Guillain-Barre syndrome in a metropolitan county, 1984- 1988. Kans Med. 1994; 95(2): 45-47.
89. McLean, M., Duclos, P., Jacob, P., Humphreys, P. Incidence of Guillain-Barre syndrome in Ontario and Quebec, 1983- 1989, using hospital service databases. Epidemiology. 1994; 5(4): 443-448.
90. Sedano, M. J., Calleja, J., Canga, E., Berciano, J. Guillain- Barre syndrome in Cantabria, Spain. An epidemiological and clinical study. Acta Neurol Scand. 1994; 89(4): 287-292.
91. Govoni, V., Granieri, E., Casetta, I., Tola, M. R., Paolino, E., Fainardi, E., Monetti, V. C. The incidence of Guillain-Barre syndrome in Ferrara, Italy: Is the disease really increasing? J Neurol Sci. 1996; 137(1): 62-68.
92. Howlett, W. P., Vedeler, C. A., Nyland, H., Aarli, J. A. Guillain-Barre syndrome in northern Tanzania: A comparison of epidemiological and clinical findings with western Norway. Acta Neurol Scand. 1996; 93(1): 44-49.
93. Emilia-Romagna. Study Group on C. A prospective study on the incidence and prognosis of Guillain-Barre syndrome in Emilia-Romagna region, Italy (1992-1993). Emilia- Romagna Study Group on Clinical and Epidemiological Problems in Neurology. Neurology. 1997; 48(1): 214-221.
94. Jiang, G. X., Cheng, Q., Link, H., de Pedro-Cuesta, J. Epidemiological features of Guillain-Barre syndrome in Sweden, 1978-93. J Neurol Neurosurg Psychiatry. 1997; 62(5): 447-453.
95. Prevots, D. R., Sutter, R. W. Assessment of Guillain-Barre syndrome mortality and morbidity in the United States: Implications for acute flaccid paralysis surveillance. J Infect Dis. 1997; 175(Suppl 1): S151-S155.
96. Rees, J. H., Thompson, R. D., Smeeton, N. C., Hughes, R. A. Epidemiological study of Guillain-Barre syndrome in south east England. J Neurol Neurosurg Psychiatry. 1998; 64(1): 74-77.
97. Cheng, Q., Jiang, G. X., Press, R., Andersson, M., Ekstedt, B., Vrethem, M., Liedholm, L. J., Lindsten, H., Brattstrom, L., Fredrikson, S., Link, H., de Pedro-Cuesta, J. Clinical epidemiology of Guillain-Barre syndrome in adults in Sweden 1996-97: A prospective study. Eur J Neurol. 2000; 7(6): 685-692.
98. Cuadrado, J. I., de Pedro-Cuesta, J., Ara, J. R., Cemillan, C. A., Diaz, M., Duarte, J., Fernandez, M. D., Fernandez, O., Garcia-Lopez, F., Garcia-Merino, A., Garcia-Montero, R., Martinez-Matos, J. A., Palomo, F., Pardo, J., Tobias, A. Guillain-Barre syndrome in Spain, 1985-1997: Epidemiological and public health views. Eur Neurol. 2001; 46(2): 83-91.
99. Cheng, Q., Wang, D. S., Jiang, G. X., Han, H., Zhang, Y., Wang, W. Z., Fredrikson, S. Distinct pattern of age-specific incidence of Guillain-Barre syndrome in Harbin, China. J Neurol. 2002; 249(1): 25-32.
100. Chio, A., Cocito, D., Leone, M., Giordana, M. T., Mora, G., Mutani, R. Guillain-Barre syndrome: A prospective, population-based incidence and outcome survey. Neurology. 2003; 60(7): 1146-1150.
101. Govoni, V., Granieri, E., Manconi, M., Capone, J., Casetta, I. Is there a decrease in Guillain-Barre syndrome incidence after bovine ganglioside withdrawal in Italy? A populationbased study in the Local Health District of Ferrara, Italy. J Neurol Sci. 2003; 216(1): 99-103.
102. Bogliun, G., Beghi, E. Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996. Acta Neurol Scand. 2004; 110(2): 100-106.
103. Chroni, E., Papapetropoulos, S., Gioldasis, G., Ellul, J., Diamadopoulos, N., Papapetropoulos, T. Guillain-Barre syndrome in Greece: Seasonality and other clinicoepidemiological features. Eur J Neurol. 2004; 11(6): 383-388.
104. Cuadrado, J. I., de Pedro-Cuesta, J., Ara, J. R., Cemillán, C. A., Díaz, M., Duarte, J., Fernández, M. D., Fernandez, O., García-López, F., García-Merino, A., Velasquez, J. M., Martínez-Matos, J. A., Palomo, F., Pardo, J., Tobías A. Spanish GBS Epidemiological Study Group. Public health surveillance and incidence of adulthood Guillain-Barré syndrome in Spain, 1998-1999: The view from a sentinel network of neurologist. Neurol Sci. 2004; 25(2): 57-65.
105. Rocha, M. S., Brucki, S. M., Carvalho, A. A., Lima, U. W. Epidemiologic features of Guillain-Barre syndrome in Sao Paulo, Brazil. Arquivos de neuro-psiquiatria. 2004; 62(1): 33-37.
106. Arami, M. A., Yazdchi, M., Khandaghi, R. Epidemiology and characteristics of Guillain-Barre syndrome in the northwest of Iran. Ann Saudi Med. 2006; 26(1): 22-27.
107. Lehmann, H. C., Kohne, A., Meyer zu Horste, G., Kieseier, B. C. Incidence of Guillain-Barre syndrome in Germany. J Peripher Nerv Syst. 2007; 12(4): 285.
108. Markoula, S., Giannopoulos, S., Sarmas, I., Tzavidi, S., Kyritsis, A. P., Lagos, G. Guillain-Barre syndrome in northwest Greece. Acta Neurol Scand. 2007; 115(3): 167-173.
109. Alshekhlee, A., Hussain, Z., Sultan, B., Katirji, B. Guillain- Barre syndrome: Incidence and mortality rates in US hospitals. Neurology. 2008; 70(18): 1608-1613.
110. Hauck, L. J., White, C., Feasby, T. E., Zochodne, D. W., Svenson, L.W., Hill, M. D. Incidence of Guillain-Barre syndrome in Alberta, Canada: An administrative data study. J Neurol Neurosurg Psychiatry. 2008; 79(3): 318-320.
111. van der Maas, N. A., Kramer, M. A., Jacobs, B. C., van Soest, E. M., Dieleman, J. P., Kemmeren, J. M., de Melker, H. E., Sturkenboom, M. C. Guillain-Barre syndrome: Background incidence rates in The Netherlands. J Peripher Nerv Syst. 2011; 16(3): 243-249.
112. Shui, I. M., Rett, M. D., Weintraub, E., Marcy, M., Amato, A. A., Sheikh, S. I., Ho, D., Lee, G. M., Yih, W. K. Vaccine Safety Datalink Research T. Guillain-Barre syndrome incidence in a large United States cohort (2000-2009). Neuroepidemiology. 2012; 39(2): 109-115.
113. Chen, Y., Ma, F., Zhang, J., Chu, X., Xu, Y. Population incidence of Guillain-Barre syndrome in parts of China: Three large populations in Jiangsu province, 2008-2010. Eur J Neurol. 2014; 21(1): 124-129.
114. Kalb, B., Matell, G., Pirskanen, R., Lambe, M. Epidemiology of myasthenia gravis: A population-based study in Stockholm, Sweden. Neuroepidemiology. 2002; 21(5): 221-225.
115. Wirtz, P. W., Nijnuis, M. G., Sotodeh, M., Willems, L. N., Brahim, J. J., Putter, H., Wintzen, A. R., Verschuuren, J. J. The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland. J Neurol. 2003; 250(6): 698-701.
116. Matsuda, M., Dohi-Iijima, N., Nakamura, A., Sekijima, Y., Morita, H., Matsuzawa, S., Sato, S., Yahikozawa, H., Tabata, K., Yanagawa, S., Ikeda, S. Increase in incidence of elderlyonset patients with myasthenia gravis in Nagano Prefecture, Japan. Intern Med. 2005; 44(6): 572-577.
117. Aiello, I., Pastorino, M., Sotgiu, S., Pirastru, M. I., Sau, G. F., Sanna, G., Rosati, G. Epidemiology of myasthenia gravis in northwestern Sardinia. Neuroepidemiology. 1997; 16(4): 199-206.
118. Andersen, J. B., Heldal, A. T., Engeland, A., Gilhus, N. E. Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. Acta Neurol Scand Suppl. 2014; (198): 26-31.
119. Aragones, J. M., Bolibar, I., Bonfill, X., Bufill, E., Mummany, A., Alonso, F., Illa, I. Myasthenia gravis: A higher than expected incidence in the elderly. Neurology. 2003; 60(6): 1024-1026.
120. Aragones, J. M., Roura-Poch, P., Hernandez-Ocampo, E. M., Alonso, F., Pont-Lluelles, M., Xandri, I., Bolibar, I., Illa, I. Myasthenia gravis: A disease of the very old. J Am Geriatr Soc. 2014; 62(1): 196-197.
121. Casetta, I., Groppo, E., De Gennaro, R., Cesnik, E., Piccolo, L., Volpato, S., Granieri, E. Myasthenia gravis: A changing pattern of incidence. J Neurol. 2010; 257(12): 2015-2019.
122. Cetin, H., Fulop, G., Zach, H., Auff, E., Zimprich, F. Epidemiology of myasthenia gravis in Austria: Rising prevalence in an ageing society. Wien Klin Wochenschr. 2012; 124(21-22): 763-768.
123. Christensen, P. B., Jensen, T. S., Tsiropoulos, I., Sorensen, T., Kjaer, M., Hojer-Pedersen, E., Rasmussen, M. J., Lehfeldt, E., de Fine Olivarius, B. Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989. Neurology. 1993; 43(9): 1779-1783.
124. Guillain-Barre syndrome variants in Emilia-Romagna, Italy, 1992-3: Incidence, clinical features, and prognosis. Emilia- Romagna Study Group on Clinical and Epidemiological Problems in Neurology. J Neurol Neurosurg Psychiatry. 1998; 65(2): 218-224.
125. Ferrari, G., Lovaste, M. G. Epidemiology of myasthenia gravis in the province of Trento (northern Italy). Neuroepidemiology. 1992; 11(3): 135-142.
126. Gattellari, M., Goumas, C., Worthington, J. M. A national epidemiological study of Myasthenia Gravis in Australia. Eur J Neurol. 2012; 19(11): 1413-1420.
127. Guidetti, D., Sabadini, R., Bondavalli, M., Cavalletti, S., Lodesani, M., Mantegazza, R., Cosi, V., Solime, F. Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy. Eur J Epidemiol. 1998; 14(4): 381-387.
128. Holtsema, H., Mourik, J., Rico, R. E., Falconi, J. R., Kuks, J. B., Oosterhuis, H. J. Myasthenia gravis on the Dutch antilles: An epidemiological study. Clin Neurol Neurosurg. 2000; 102(4): 195-198.
129. Lai, C. H., Tseng, H. F. Nationwide population-based epidemiological study of myasthenia gravis in taiwan. Neuroepidemiology. 2010; 35(1): 66-71.
130. Lavrnic, D., Jarebinski, M., Rakocevic-Stojanovic, V., Stevic, Z., Lavrnic, S., Pavlovic, S., Trikic, R., Tripkovic, I., Neskovic, V., Apostolski, S. Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992). Acta Neurol Scand. 1999; 100(3): 168-174.
131. Maharaj, J., Bahadursingh, S., Ramcharan, K. Myasthenia gravis in South Trinidad. West Indian Med J. 2013; 62(6): 510-514.
132. Matsui, N., Nakane, S., Nakagawa, Y., Kondo, K., Mitsui, T., Matsumoto, T., Arisawa, K., Kaji, R. Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan. J Neurol Neurosurg Psychiatry. 2009; 80(10): 1168-1171.
133. Matuja, W. B., Aris, E. A., Gabone, J., Mgaya, E. M. Incidence and characteristics of Myasthenia gravis in Dar Es Salaam, Tanzania. East Afr Med J. 2001; 78(9): 473-476.
134. Montomoli, C., Citterio, A., Piccolo, G., Cioccale, R., Ferretti, V. V., Fratti, C., Bergamaschi, R., Cosi, V. E. Epidemiology and geographical variation of myasthenia gravis in the province of Pavia, Italy. Neuroepidemiology. 2012; 38(2): 100-105.
135. Murai, H., Yamashita, N., Watanabe, M., Nomura, Y., Motomura, M., Yoshikawa, H., Nakamura, Y., Kawaguchi, N., Onodera, H., Araga, S., Isobe, N., Nagai, M., Kira, J. Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey. J Neurol Sci. 2011; 305(1-2): 97-102.
136. Oopik, M., Puksa, L., Luus, S. M., Kaasik, A. E., Jakobsen, J. Clinical and laboratory-reconfirmed myasthenia gravis: A population-based study. Eur J Neurol. 2008; 15(3): 246-252.
137. Pallaver, F., Riviera, A. P., Piffer, S., Ricciardi, R., Roni, R., Orrico, D., Bonifati, D. M. Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years. Neuroepidemiology. 2011; 36(4): 282-287.
138. Pedersen, E. G., Hallas, J., Hansen, K., Jensen, P. E., Gaist, D. Late-onset myasthenia not on the increase: A nationwide register study in Denmark, 1996-2009. Eur J Neurol. 2013; 20(2): 309-314.
139. Phillips, L. H., 2nd, Torner, J. C., Anderson, M. S., Cox, G. M. The epidemiology of myasthenia gravis in central and western Virginia. Neurology. 1992; 42(10): 1888-1893.
140. Robertson, N. P., Deans, J., Compston, D. A. Myasthenia gravis: A population based epidemiological study in Cambridgeshire, England. J Neurol Neurosurg Psychiatry. 1998; 65(4): 492-496.
141. Sardu, C., Cocco, E., Mereu, A., Massa, R., Cuccu, A., Marrosu, M. G., Contu, P. Population based study of 12 autoimmune diseases in Sardinia, Italy: Prevalence and comorbidity. PLoS One. 2012; 7(3): e32487.
142. Somnier, F. E., Keiding, N., Paulson, O. B. Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey. Arch Neurol. 1991; 48(7): 733-739.
143. Yu, Y. L., Hawkins, B. R., Ip, M. S., Wong, V., Woo, E. Myasthenia gravis in Hong Kong Chinese. 1. Epidemiology and adult disease. Acta Neurol Scand. 1992(2); 86:113-119.
144. Zivadinov, R., Jurjevic, A., Willheim, K., Cazzato, G., Zorzon, M. Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996. Neuroepidemiology. 1998; 17(5): 265-272.
145. Wirtz, P.W., van Dijk, J. G., van Doorn, P. A., van Engelen, B. G., van der Kooi, A. J., Kuks, J. B., Twijnstra, A., de Visser, M., Visser, L. H., Wokke, J. H., Wintzen, A. R., Verschuuren, J. J. The epidemiology of the Lambert-Eaton myasthenic syndrome in the Netherlands. Neurology. 2004; 63(2): 397-398.
146. Nakagawa, M., Nakahara, K., Yoshidome, H., Suehara, M., Higuchi, I., Fujiyama, J., Nakamura, A., Kubota, R., Takenaga, S., Arahata, K. et al. Epidemiology of progressive muscular dystrophy in Okinawa, Japan. Classification with molecular biological techniques. Neuroepidemiology. 1991; 10(4): 185-191.
147. van Essen, A. J., Busch, H. F., teMeerman, G. J., ten Kate, L. P. Birth and population prevalence of Duchenne muscular dystrophy in The Netherlands. Hum Genet. 1992; 88(3): 258-266.
148. Siciliano, G., Tessa, A., Renna, M., Manca, M. L., Mancuso, M., Murri, L. Epidemiology of dystrophinopathies in North- West Tuscany:Amolecular genetics-based revisitation. Clin Genet. 1999; 56(1): 51-58.
149. Jeppesen, J., Green, A., Steffensen, B. F., Rahbek, J. The Duchenne muscular dystrophy population in Denmark, 1977-2001: Prevalence, incidence and survival in relation to the introduction of ventilator use. Neuromuscul Disord. 2003; 13(10): 804-812.
150. Bushby, K. M., Thambyayah, M., Gardner-Medwin, D. Prevalence and incidence of Becker muscular dystrophy. Lancet. 1991; 337(8748): 1022-1024.
151. Mostacciuolo, M. L., Miorin, M., Pegoraro, E., Fanin, M., Schiavon, F., Vitiello, L., Saad, F. A., Angelini, C., Danieli, G. A. Reappraisal of the incidence rate of Duchenne and Becker muscular dystrophies on the basis of molecular diagnosis. Neuroepidemiology. 1993; 12(6): 326-330.
152. Ballo, R., Viljoen, D., Beighton, P., Duchenne, and. Becker muscular dystrophy prevalence in South Africa and molecular findings in 128 persons affected. S Afr Med J. 1994; 84(8 Pt 1): 494-497.
153. Peterlin, B., Zidar, J., Meznaric-Petrusa, M., Zupancic, N. Genetic epidemiology of Duchenne and Becker muscular dystrophy in Slovenia. Clin Genet. 1997; 51(2): 94-97.
154. Flanigan, K. M., Coffeen, C. M., Sexton, L., Stauffer, D., Brunner, S., Leppert, M. F. Genetic characterization of a large, historically significant Utah kindred with facioscapulohumeral dystrophy. Neuromuscul Disord. 2001; 11(6-7): 525-529.
155. Mostacciuolo, M. L., Pastorello, E., Vazza, G., Miorin, M., Angelini, C., Tomelleri, G., Galluzzi, G., Trevisan, C. P. Facioscapulohumeral muscular dystrophy: Epidemiological and molecular study in a north-east Italian population sample. Clin Genet. 2009; 75(6): 550-555.
156. van der Kooi, A. J., Barth, P. G., Busch, H. F., de Haan, R., Ginjaar, H. B., van Essen, A. J., van Hooff, L. J., Howeler, C. J., Jennekens, F. G., Jongen, P., Oosterhuis, H. J., Padberg, G.W., Spaans, F., Wintzen, A. R., Wokke, J. H., Bakker, E., van Ommen, G. J., Bolhuis, P. A., de Visser, M. The clinical spectrum of limb girdle muscular dystrophy. A survey in The Netherlands. Brain. 1996; 119 (Pt 5): 1471-1480.
157. Urtasun, M., Saenz, A., Roudaut, C., Poza, J. J., Urtizberea, J. A., Cobo, A. M., Richard, I., Garcia Bragado, F., Leturcq, F., Kaplan, J. C., Marti Masso, J. F., Beckmann, J. S., Lopez de Munain, A. Limb-girdle muscular dystrophy in Guipuzcoa (Basque Country, Spain). Brain. 1998; 121(Pt 9): 1735-1747.
158. Lopez de Munain, A., Blanco, A., Emparanza, J. I., Poza, J. J., Marti Masso, J. F., Cobo, A., Martorell, L., Baiget, M., Martinez Lage, J. M. Prevalence of myotonic dystrophy in Guipuzcoa (Basque Country, Spain). Neurology. 1993; 43(8): 1573-1576.
159. Medica, I., Markovic, D., Peterlin, B. Genetic epidemiology of myotonic dystrophy in Istria, Croatia. Acta Neurol Scand. 1997; 95(3):164-166.
160. Segel, R., Silverstein, S., Lerer, I., Kahana, E., Meir, R., Sagi, M., Zilber, N., Korczyn, A. D., Shapira, Y., Argov, Z., Abeliovich, D. Prevalence of myotonic dystrophy in Israeli Jewish communities: Inter-community variation and founder premutations. Am J Med Genet A. 2003; 119A(3): 273-278.
161. Ford, C., Kidd, A., Hammond-Tooke, G. Myotonic dystrophy in Otago, New Zealand. N Z Med J. 2006; 119(1241): U2145.
162. Mostacciuolo, M. L., Miorin, M., Martinello, F., Angelini, C., Perini, P., Trevisan, C. P. Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy. Hum Genet. 1996; 97(3): 277-279.
163. Amburgey, K., McNamara, N., Bennett, L. R., McCormick, M. E., Acsadi, G., Dowling, J. J. Prevalence of congenital myopathies in a representative pediatric united states population. Ann Neurol. 2011; 70(4): 662-665.
164. Casetta, I., Fallica, E., Govoni, V., Azzini, C., Tola, M., Granieri, E. Incidence of myasthenia gravis in the province of Ferrara: A community-based study. Neuroepidemiology. 2004; 23(6): 281-284.
165. Oddis, C. V., Conte, C. G., Steen, V. D., Medsger, T. A. Jr. Incidence of polymyositis-dermatomyositis: A 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol. 1990; 17(10): 1329-1334.
166. Wilson, F. C., Ytterberg, S. R., St Sauver, J. L., Reed, A. M. Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota. J Rheumatol. 2008; 35(3): 445-447.
167. Furst, D. E., Amato, A. A., Iorga, S. R., Gajria, K., Fernandes, A. W. Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan. Muscle Nerve. 2012; 45(5): 676-683.
168. Rosa, J., Garrot, L. F., Navarta, D. A., Saucedo, C., Scolnik, M., Bedran, Z., Garcia, M. V., Sabelli, M., Catoggio, L. J., Soriano, E. R. Incidence and prevalence of polymyositis and dermatomyositis in a health management organization in Buenos Aires. J Clin Rheumatol. 2013; 19(6): 303-307.
169. See, L. C., Kuo, C. F., Chou, I. J., Chiou, M. J., Yu, K. H. Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: A Taiwan populationbased study. Semin Arthritis Rheum. 2013; 43(3): 381-386.
170. Tan, J. A., Roberts-Thomson, P. J., Blumbergs, P., Hakendorf, P., Cox, S. R., Limaye, V. Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: A 30-year epidemiologic study of histology-proven cases. Int J Rheum Dis. 2013; 16(3): 331-338.
171. Bendewald, M. J., Wetter, D. A., Li, X., Davis, M. D. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: A population-based study in Olmsted County, Minnesota. Arch Dermatol. 2010; 146(1): 26-30.
172. Kaipiainen-Seppanen, O., Aho, K. Incidence of rare systemic rheumatic and connective tissue diseases in Finland. J Intern Med. 1996; 240(2): 81-84.
173. Badrising, U. A., Maat-Schieman, M., van Duinen, S. G., Breedveld, F., van Doorn, P., van Engelen, B., van den Hoogen, F., Hoogendijk, J., Howeler, C., de Jager, A., Jennekens, F., Koehler, P., van der Leeuw, H., de Visser, M., Verschuuren, J. J., Wintzen, A. R. Epidemiology of inclusion body myositis in the Netherlands: A nationwide study. Neurology. 2000; 55(9):1385-1387.
174. Phillips, B. A., Zilko, P. J., Mastaglia, F. L. Prevalence of sporadic inclusion body myositis in Western Australia. Muscle Nerve. 2000; 23(6):970-972.
175. Oflazer, P. S., Deymeer, F., Parman, Y. Sporadic-inclusion body myositis (s-IBM) is not so prevalent in Istanbul/ Turkey: A muscle biopsy based survey. Acta Myol. 2011; 30(1): 34-36.
176. Suzuki, N., Aoki, M., Mori-Yoshimura, M., Hayashi, Y. K., Nonaka, I., Nishino, I. Increase in number of sporadic inclusion body myositis (sIBM) in Japan. J Neurol. 2012; 259(3): 554-556.
177. European Commission. Rare diseases policy: What are they? 2012 [cited 2014 May 22]; Available from: http://ec.europa. eu/health/rare diseases/policy/index en.htm.
178. Wirdefeldt, K., Adami, H. O., Cole, P., Trichopoulos, D., Mandel, J. Epidemiology and etiology of Parkinson's disease: A review of the evidence. Eur J Epidemiol. 2011(26 Suppl 1: S1-S58.
179. Atlas multiple sclerosis resources in the world 2008. Place. Published: World Health Organisation; 2008.